Chromium/biotin treatment of type ii diabetes

Details Chromium/biotin treatment of type ii diabetes Chromium/biotin treatment of type ii diabetes

A - Human Necessities

61

K

A61K 33/24 (2006.01) A61K 31/4188 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2297834

A method for treating Type II diabetes by administering to an affected individual a combination of chromic tripicolinate and biotin. The two compounds are administered orally or parenterally at in daily dosages which provide between 50 and 1,000 µg of chromium and between 25 µg and 200 mg biotin, the amounts of chromium and biotin being selected together to provide a greater than additive effect.

Une méthode de traitement du diabète de type II par administration à un individu affecté d'une combinaison de tripicolinate chromique et de biotine. Les deux composés sont administrés par voie orale ou parentérale selon des dosages quotidiens prévoyants de 50 à 1000 mu g de chrome et de 25 mu à 200 mg de biotine, les doses du chrome et de la biotine étant sélectionnées ensemble afin d'obtenir un effet supérieur à un effet additif.

Affiliated with

Also associated with

Rating

Chromium/biotin treatment of type ii diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chromium/biotin treatment of type ii diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromium/biotin treatment of type ii diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1533561